Neopharmed gentili acquires MDM
Milan, 31 October 2019. Neopharmed Gentili, a leading ltalian pharmaceutical company active in the marketing of high-value therapeutic solutions controlled by Ardian and the Del Bono family, acquired 1 00% of MDM, a pharmaceutical company based in Monza active in the distribution of pharmaceuticals, nutraceuticals and medicai devices far neurology and orthopedics.
Ardian acquires the majority of Neopharmed Gentili, a subsidiary of Mediolanum Farmaceutici
Milan, 28 November 2018 – Mediolanum Farmaceutici, a pharmaceutical company founded in 1972 by the Del Bono family and now one of the main actors in the Italian market, particularly in the treatment of diseases in the cardiovascular area, has chosen Ardian, a leading global private equity firm, as their strategic partner to continue pursuing the national and international growth plan of its subsidiary Neopharmed Gentili.